NXPI vs PTCT · P/E 29, rev $12.27B vs rev $633.1M
NXP Semiconductors NV (NXPI) versus PTC Therapeutics Inc (PTCT) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
PTC Therapeutics Inc (PTCT) is a biotechnology company listed on NASDAQ.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Latest reported PTCT revenue for 2026-06-30 was $633.1M. Net income was $80.7M. PTCT currently screens at market cap $6.51B.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. PTCT currently screens at market cap $6.51B.
Not investment advice. Open the NXPI and PTCT stock pages for the full models.
Not investment advice.